CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-12 | Trowbridge Stephen A EVP and CFO | Purchase | +1,083 | $13.82 | $15K | 89,581 |
| 2022-10-10 | Clemmer James C President and CEO | Purchase | +10,000 | $15.00 | $150K | 450,407 |
| 2022-07-29 | Helsel Dave SVP Global Operations and R&D | Sale | −5,000 | $22.44 | $112K | 23,822 |
| 2022-07-20 | Clemmer James C President and CEO | Grant or award | +33,094 | 440,407 | ||
| 2022-07-20 | Clemmer James C President and CEO | Grant or award · Performance Right | +66,187 | 66,187 | ||
| 2022-07-20 | Clemmer James C President and CEO | Grant or award · Non- Qualified Stock Option (right to buy) | +77,530 | 77,530 | ||
| 2022-07-20 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award | +3,987 | 37,754 | ||
| 2022-07-20 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award · Performance Right | +7,974 | 7,974 | ||
| 2022-07-20 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award · Non- Qualified Stock Option (right to buy) | +9,341 | 9,341 | ||
| 2022-07-20 | Nighan Warren JR SVP Quality and Regulatory | Grant or award | +3,426 | 39,619 | ||
| 2022-07-20 | Nighan Warren JR SVP Quality and Regulatory | Grant or award · Performance Right | +6,852 | 6,852 | ||
| 2022-07-20 | Nighan Warren JR SVP Quality and Regulatory | Grant or award · Non- Qualified Stock Option (right to buy) | +8,027 | 8,027 | ||
| 2022-07-20 | Helsel Dave SVP Global Operations and R&D | Grant or award | +3,691 | 28,822 | ||
| 2022-07-20 | Helsel Dave SVP Global Operations and R&D | Grant or award · Performance Right | +7,381 | 7,381 | ||
| 2022-07-20 | Helsel Dave SVP Global Operations and R&D | Grant or award · Non-Qualified Stock Option (right to buy) | +8,646 | 8,646 | ||
| 2022-07-20 | Piccinini Laura SVP International | Grant or award | +4,402 | 7,354 | ||
| 2022-07-20 | Piccinini Laura SVP International | Grant or award · Performance Right | +8,803 | 8,803 | ||
| 2022-07-20 | Piccinini Laura SVP International | Grant or award · Non- Qualified Stock Option (right to buy) | +10,312 | 10,312 | ||
| 2022-07-20 | ROSENZWEIG RICHARD C SVP and General Counsel | Grant or award | +3,963 | 16,867 | ||
| 2022-07-20 | ROSENZWEIG RICHARD C SVP and General Counsel | Grant or award · Performance Right | +7,925 | 7,925 |
Page 13 of 30 · 589 trades